Revenio Group Oyj REG1V
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €35.36
- Day Range
- €34.74–35.60
- 52-Week Range
- €17.51–35.76
- Bid/Ask
- €34.80 / €34.86
- Market Cap
- €923.94 Mil
- Volume/Avg
- 8,290 / 13,935
Key Statistics
- Price/Earnings (Normalized)
- 45.32
- Price/Sales
- 9.20
- Dividend Yield (Trailing)
- 1.09%
- Dividend Yield (Forward)
- 1.09%
- Total Yield
- 1.09%
Company Profile
Revenio Group Oyj is a Finnish health technology company. It develops and commercializes effective and easy-to-use health tech-related screening devices for the detection of diseases of significance to public health. Its ophthalmic diagnostic solutions includes intraocular pressure (IOP) measurement devices (tonometers), perimeter and fundus imaging devices under the iCare brand. Its eye care software platform Oculo offers clinical communication, telehealth, remote patient monitoring, and data analytics capabilities. The company's geographical segments include Finland, Other Europe, and Others.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 227
- Website
- https://www.reveniogroup.fi
Comparables
Valuation
|
Metric
|
REG1V
|
HEALTH
|
300869
|
|---|---|---|---|
Price/Earnings (Normalized) | 45.32 | — | 40.71 |
Price/Book Value | 9.46 | 2.06 | 3.00 |
Price/Sales | 9.20 | 50.95 | 13.06 |
Price/Cash Flow | 38.18 | — | 174.10 |
Price/Earnings
REG1V
HEALTH
300869
Financial Strength
|
Metric
|
REG1V
|
HEALTH
|
300869
|
|---|---|---|---|
Quick Ratio | 1.63 | 14.15 | 7.03 |
Current Ratio | 2.16 | 14.23 | 10.42 |
Interest Coverage | 5,077.80 | −750.52 | −0.79 |
Quick Ratio
REG1V
HEALTH
300869
Profitability
|
Metric
|
REG1V
|
HEALTH
|
300869
|
|---|---|---|---|
Return on Assets (Normalized) | 14.57% | −14.28% | −0.83% |
Return on Equity (Normalized) | 19.94% | −15.59% | −1.34% |
Return on Invested Capital (Normalized) | 18.75% | −15.41% | −1.30% |
Return on Assets
REG1V
HEALTH
300869
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Rrwlwjb | Mqbdvyr | $195.6 Bil | |||
| Stryker Corp
SYK
| Dlptkfdrj | Ydps | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Wsjzzgprf | Rfgnwm | $122.7 Bil | |||
| Medtronic PLC
MDT
| Ykpmbfgh | Zfply | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Nbvzwbzbsp | Nlylhr | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Nzhg | Zpfr | $30.7 Bil | |||
| DexCom Inc
DXCM
| Kzwdzlfny | Dpzg | $27.0 Bil | |||
| Steris PLC
STE
| Zdnghcpsq | Bwlygw | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Xhskjphjwm | Mng | $22.0 Bil | |||
| Insulet Corp
PODD
| Rwhttgyhh | Ymkcqt | $16.3 Bil |
United States